None

Temozolomide (Temozolomide) is a chemotherapy drug, not a targeted drug. It belongs to a class of drugs called DNA base repair enzyme inhibitors. Its mechanism of action is through methylation reaction in tumor cells, causing damage and breakage of DNA chains, thereby hindering the proliferation and viability of tumor cells. Temozolomide, an alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma, works by slowing or stopping the growth of cancer cells in your body.

Although temozolomide has a specific effect on tumor cells, it does not achieve therapeutic effects by targeting specific molecular targets, but by affecting the DNA repair process. Therefore, temozolomide is classified as a chemotherapy drug rather than a targeted drug. It should be noted that targeted drugs refer to drugs that can selectively target specific molecules or signaling pathways, thereby interfering with the growth and viability of tumor cells. Compared with traditional chemotherapy drugs, targeted drugs can act on cancer cells more accurately, reduce damage to normal tissues, improve efficacy and reduce side effects.

The original drug temozolomide has been launched in China and has entered the scope of Class B medical insurance. Common specificationsThe price of 100mg*1 tablet*5 bags per box may be around 2,000 yuan. The price of generic temozolomide drugs marketed overseas is relatively low, and its pharmaceutical ingredients are basically the same as those of the original temozolomide drug. For example, the price of a box of 100mg*5 produced by a Bangladeshi pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to exchange rates).